Literature DB >> 22692884

The incidence of invasion and metastasis of nasopharyngeal carcinoma at different anatomic sites in the skull base.

Jun Han1, Qiuhang Zhang, Feng Kong, Yongan Gao.   

Abstract

This study aimed to investigate the incidence of direct invasion and metastasis of nasopharyngeal carcinoma (NPC) at different anatomic sites in the skull base using magnetic resonance imaging (MRI). MRI data from 101 NPC patients with skull base invasion were collected and we analyzed the incidence and anatomic sites of invasion of NPC in the skull base. Of the 101 NPC patients, 84 had direct invasion at the skull base (83.2%), and 17 had skull base metastasis (16.8%). Affected sites with direct invasion in the skull base included sphenoid sinus and sella base, cavernous sinus, internal carotid canal, and clivus blumenbachii. Skull base metastasis sites included the internal carotid canal and jugular foramen area. Because of early lymphatic metastasis of NPC to the skull base, MRI examination can be helpful in increasing the accuracy of diagnostic imaging for skull base invasion of NPC and selecting appropriate target sites, radiotherapy techniques, and operative approaches.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22692884     DOI: 10.1002/ar.22507

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  2 in total

1.  Neurosurgical interventions for patients with nasopharyngeal carcinoma: a single institution experience.

Authors:  Ke Sai; Yong-gao Mou; Jing Zeng; Yan-chun Lv; Shao-yan Xi; Su Guan; Xiang-heng Zhang; Jian Wang; Chao Ke; Jian-gui Guo; Yin-sheng Chen; Zhong-ping Chen
Journal:  World J Surg Oncol       Date:  2013-09-13       Impact factor: 2.754

2.  Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.

Authors:  Chen Wang; Lidong Liu; Shaolv Lai; Danke Su; Younan Liu; Guanqiao Jin; Xuna Zhu; Ningbin Luo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.